|
Market Closed -
Nasdaq
21:00:00 28/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.160 USD | -0.63% |
|
-1.25% | -48.62% |
| 07-31 | Myriad Genetics, Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Myriad Genetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq
MYGN 3.160 $
-0.63%
4.52M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| MYGN | 3.160USD | -0.63% | 4.52M $ | |
CBOE
| MYGN | 3.145USD | -0.94% | 373K $ | |
Börse Stuttgart
| MYD | 2.703EUR | +0.30% | 8.11K € | |
Tradegate
| MYD | 2.715EUR | -0.40% | 7.24K € | |
Boerse Muenchen
| MYD | 2.706EUR | -1.01% | 184.01 € | |
Deutsche Boerse AG
| MYD | 2.674EUR | +1.56% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 4.25 | 4.25 | 4.8 |
| Spread/Res. | -25.65% | -25.65% | -34.17% |
| Spread/Supp. | +10.49% | +10.49% | +10.49% |
| Support | 2.86 | 2.86 | 2.86 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MYGN Stock
- Charts Myriad Genetics, Inc.
Select your edition
All financial news and data tailored to specific country editions

















